122299-11-0 Usage
Uses
Used in Pharmaceutical Industry:
EGLIN C (41-49) is used as an anti-inflammatory agent for its ability to specifically inhibit the activity of human neutrophil elastase, a key enzyme in inflammatory processes. This targeted inhibition makes it a promising compound for the treatment of conditions such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other inflammatory disorders.
Used in Research and Development:
In the field of anti-inflammatory therapeutics, EGLIN C (41-49) is utilized as a research compound to further understand the role of HNE in inflammation and to develop new treatments that can effectively manage inflammatory conditions without affecting other related enzymes, thereby increasing the safety and specificity of potential drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 122299-11-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,2,2,9 and 9 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 122299-11:
(8*1)+(7*2)+(6*2)+(5*2)+(4*9)+(3*9)+(2*1)+(1*1)=110
110 % 10 = 0
So 122299-11-0 is a valid CAS Registry Number.
InChI:InChI=1/C48H78N12O15/c1-23(2)18-31(41(68)53-30(11-9-17-52-48(49)50)40(67)55-33(20-27-12-14-28(63)15-13-27)43(70)58-35(22-61)47(74)75)54-44(71)34(21-36(64)65)56-42(69)32(19-24(3)4)57-46(73)38(26(7)62)60-45(72)37(25(5)6)59-39(66)29-10-8-16-51-29/h12-15,23-26,29-35,37-38,51,61-63H,8-11,16-22H2,1-7H3,(H,53,68)(H,54,71)(H,55,67)(H,56,69)(H,57,73)(H,58,70)(H,59,66)(H,60,72)(H,64,65)(H,74,75)(H4,49,50,52)/t26-,29+,30+,31+,32+,33+,34+,35+,37+,38+/m1/s1
122299-11-0Relevant articles and documents
Amino acids and peptides. XXXVII. Synthesis of stereoisomeric nonapeptides corresponding to sequence 41-49 of eglin c and examination of their inhibitory activity against human leukocyte cathepsin G and α-chymotrypsin
Fujii,Tsuboi,Asada,Nagamatsu,Yamamoto,Okada
, p. 1518 - 1521 (2007/10/02)
A nonapeptide, H-Ser-Pro-Val-Thr-Leu-Asp-Leu-Arg-Tyr-OH, corresponding to sequence 41-49 of eglin c inhibited leukocyte cathepsin G and α-chymotrypsin with K(i) values of 2.2 x 10-5 and 7.2 x 10-6 M, respectively, although eglin c it